Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,355,000 papers from all fields of science
Search
Sign In
Create Free Account
olesoxime
Known as:
cholest-4-en-3-one, oxime
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Narrower (1)
TRO19622
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Targeting the Multiple Physiologic Roles of VDAC With Steroids and Hydrophobic Drugs
T. Rostovtseva
,
M. Queralt-Martín
,
William M. Rosencrans
,
S. Bezrukov
Frontiers in Physiology
2020
Corpus ID: 218870477
There is accumulating evidence that endogenous steroids and non-polar drugs are involved in the regulation of mitochondrial…
Expand
2017
2017
Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts
A. Salameh
,
M. Keller
,
I. Dähnert
,
S. Dhein
The thoracic and cardiovascular surgeon
2017
Corpus ID: 21461947
Objective: During cardioplegia, which is often used in cardiac surgery, the heart is subjected to global ischemia/reperfusion…
Expand
2016
2016
The calpain-suppressing effects of olesoxime in Huntington's disease
J. Weber
,
Midea M. Ortiz Rios
,
O. Riess
,
L. E. Clemens
,
H. Nguyen
Rare Diseases
2016
Corpus ID: 11599739
ABSTRACT Olesoxime, a small molecule drug candidate, has recently attracted attention due to its significant beneficial effects…
Expand
2016
2016
Similar oxysterols may lead to opposite effects on synaptic transmission: Olesoxime versus 5α-cholestan-3-one at the frog neuromuscular junction.
M. R. Kasimov
,
G. F. Zakyrjanova
,
A. Giniatullin
,
Andrey L. Zefirov
,
Alexey M. Petrov
Biochimica et Biophysica Acta
2016
Corpus ID: 19601096
Highly Cited
2015
Highly Cited
2015
Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial
Muhammad Khizar Rafiq
,
Ellen Lee
,
M. Bradburn
,
C. Mcdermott
,
P. Shaw
Amyotrophic Lateral Sclerosis and Frontotemporal…
2015
Corpus ID: 28571499
Patients with ALS may have insufficientenergy substrates, due to dysphagia and hypermetabolism, which adversely affects the…
Expand
2015
2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
L. E. Clemens
,
J. Weber
,
+14 authors
H. Nguyen
Brain : a journal of neurology
2015
Corpus ID: 9611377
Huntington's disease is a fatal human neurodegenerative disorder caused by a CAG repeat expansion in the HTT gene, which…
Expand
2013
2013
Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF
C. Gouarné
,
Marc Giraudon-Paoli
,
+4 authors
T. Bordet
British Journal of Pharmacology
2013
Corpus ID: 22814934
Olesoxime is a small cholesterol–oxime promoting rat embryonic motor neurons survival in the absence of trophic factors. Because…
Expand
2011
2011
Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis
A. Ghanizadeh
Molecular Syndromology
2011
Corpus ID: 345122
Excitotoxicity, oxidative stress, and mitochondrial dysfunction are associated with autism. Considering the preventive role of…
Expand
Review
2010
Review
2010
Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.
L. Martin
IDrugs : the investigational drugs journal
2010
Corpus ID: 6884827
Effective therapies are needed for amyotrophic lateral sclerosis (ALS), a debilitating and fatal motor neuron disease. Cell and…
Expand
2010
2010
Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.
A. Rovini
,
M. Carré
,
T. Bordet
,
R. Pruss
,
D. Braguer
Biochemical Pharmacology
2010
Corpus ID: 9895772
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE